CELL-CELL BIO
The computed 12-month bankruptcy probability of CELL-CELL BIO is 0.1% (very low). The 2024 annual accounts show equity of €455k and a net result of €22k. Equity is growing by ~4.5% per year across the filed fiscal years. Its solvency ranks better than 62% of 382 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €455k |
| Net result | €22k |
| Staff (FTE) | 3 |
| Better than sector | 62% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 65.7% | 50.3% | |
| Net result | €22k | €72k | |
| Equity | €455k | €127k | |
| Gross operating margin | €455k | €179k | |
| Staff costs | €246k | €134k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €199k |
| Net profit | €22k |
| Cash flow | €199k |
| Staff costs | €246k |
| Income taxes | €160 |
| Dividends | - |
| Total assets | €692k |
| Equity | €455k |
| Debt | €237k |
| of which ≤ 1y | €37k |
| of which > 1y | €200k |
| Working capital | €120k |
| Employees (FTE) | 3.0 |
| 2024 | |
|---|---|
| Current ratio | 4.24 |
| Quick ratio | 4.24 |
| Working capital ratio | 17.3% |
| Solvency | 65.7% |
| Debt / equity | 0.52 |
| Long-term debt ratio | 0.44 |
| Interest coverage | 368.34 |
| Gross margin | - |
| Net margin | - |
| ROA | 3.2% |
| ROE | 4.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €692k |
| Fixed assets | 21/28 | €535k |
| Intangible fixed assets | 21 | €524k |
| Tangible fixed assets | 22/27 | €11k |
| Current assets | 29/58 | €157k |
| Amounts receivable within one year | 40/41 | €51k |
| Cash & bank | 54/58 | €105k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €692k |
| Equity | 10/15 | €455k |
| Contributions / capital | 10/11 | €500k |
| Accumulated profits (losses) | 14 | €-45k |
| Amounts payable | 17/49 | €237k |
| Amounts payable after one year | 17 | €200k |
| Amounts payable within one year | 42/48 | €37k |
| Trade debts payable within one year | 44 | €15k |
| Income statement | ||
| Gross operating margin | 9900 | €455k |
| Operating result | 9901 | €22k |
| Financial income | 75 | €800 |
| Financial charges | 65 | €539 |
| Result before taxes | 9903 | €22k |
| Income taxes | 67/77 | €160 |
| Net result for the period | 9904 | €22k |
| Result to be appropriated | 9905 | €22k |
-
MaRaLegal entityDirector· perm. rep.: Hendrik ThysState Gazette act 26010321 (21-01-2026)Current30-06-2025 → present
Former directors (2)
-
Former- → 30-06-2025
-
Former- → 18-10-2024
| NACE primary | Human health(86910) |
| Legal form | Public limited company(014) |
| Incorporation | 25-02-2022 |
| Status | Active |
| Postal code | 9052 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44082A0019/00Y000 | Flanders | 6,744 m² | 1 · 795 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
21-01-2026 1 director appointed, 2 resigning
- Hendrik Thys, Bestuurder
- Lara van Opdorp, Bestuurder
- Hendrik Thys, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lara van Opdorp",
"address": null,
"birth_date": null
},
"effective_date": "2024-10-18",
"evidence_quote": "de vergadering kennisgenomen heeft van het ontslag als bestuurder van Lara van Opdorp, wonende te 8210 Zedelgem, Werveken 22 bus 0001 met ingang van 18/10/2024"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hendrik Thys",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-30",
"evidence_quote": "de vergadering kennisgenomen heeft van het ontslag als bestuurder van Hendrik Thys, wonende te 8500 Kortrijk, Burgemeester Danneelstraat 86 met ingang van 30/06/2025"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hendrik Thys",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "MaRa",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-30",
"evidence_quote": "de vergadering beslist heeft om de besloten vennootschap MaRa, met zetel te 8500 Kortrijk, Burgmeester Danneelstraat 86, ingeschreven in het rechtspersonenregister onder het nummer 1005.3456 te benoemen als bestuurder met ingang van 30/06/2025"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0782.638.362",
"name_full": "CELL-CELL BIO",
"legal_form": "NV"
}
}09-09-2024 Registered office moved from Oostkamp to Gent
- Legeweg 157, 8020 Oostkamp → Rijvisschestraat 120, 9052 Gent
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gent",
"region": null,
"street": "Rijvisschestraat",
"country": "BE",
"postcode": "9052",
"box_number": null,
"street_number": "120"
},
"old_address": {
"city": "Oostkamp",
"region": null,
"street": "Legeweg",
"country": "BE",
"postcode": "8020",
"box_number": "C",
"street_number": "157"
},
"effective_date": "2024-08-07",
"evidence_quote": "Uit de notulen van de raad van bestuur gehouden in datum van 07/08/2024 blijkt dat de vergadering beslist heeft om de zetel van de vennootschap met ingang van 07/08/2024, naar het volgend adres te verplaatsen: 9052 Gent, Rijvisschestraat 120"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0782.638.362",
"name_full": "CELL-CELL BIO",
"legal_form": "NV"
}
}01-03-2022 Incorporation of a new NV
Technical details
{
"kind": "oprichting",
"seat": "Legeweg 157 bus C, 8020 Oostkamp",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0781.483.468",
"name": "DOING WELL BY DOING GOOD"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Stemrecht",
"partner_role": null,
"holder_org_kbo": "0781.483.468",
"holder_org_name": "DOING WELL BY DOING GOOD",
"contribution_type": "cash",
"amount_paid_in_eur": 490000,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 4900,
"amount_subscribed_eur": 490000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1994-08-31",
"name": "VAN OPDORP Lara Marie",
"niss": null,
"address": "Speystraat 15, 8340 Damme"
},
"share_class": "Stemrecht",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "VAN OPDORP Lara Marie",
"is_subscriber_only": true,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1990-01-02",
"name": "THYS Hendrik Luk",
"niss": null,
"address": "Burgemeester Pyckestraat 51, 8500 Kortrijk"
},
"share_class": "Stemrecht",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 5000,
"holder_person_name": "THYS Hendrik Luk",
"is_subscriber_only": true,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 5000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 500000,
"subject_company": {
"kbo": "0782.638.362",
"name_full": "CELL-CELL BIO",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2022-02-24",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | CELL-CELL BIO |